Karin Hansson

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Hodgkin Lymphoma

Top Venues

Nature communications

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone, Karin Hansson, Ian Evans, Axel Behrens, Rocio Sancho
USP7 controls NGN3 stability and pancreatic endocrine lineage development. Nature communications 14 (1) (2023)
Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone, Karin Hansson, Ian Evans, Axel Behrens, Rocio Sancho
USP7 controls NGN3 stability and pancreatic endocrine lineage development. Nature communications 14 (1) (2023)
Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone, Karin Hansson, Ian Evans, Axel Behrens, Rocio Sancho
USP7 controls NGN3 stability and pancreatic endocrine lineage development. Nature communications 14 (1) (2023)
Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone, Karin Hansson, Ian Evans, Axel Behrens, Rocio Sancho
USP7 controls NGN3 stability and pancreatic endocrine lineage development. Nature communications 14 (1) (2023)
Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone, Karin Hansson, Ian Evans, Axel Behrens, Rocio Sancho
USP7 controls NGN3 stability and pancreatic endocrine lineage development. Nature communications 14 (1) (2023)
Adriana Mañas, Kristina Aaltonen, Natalie Andersson, Karin Hansson, Aleksandra Adamska, Alexandra Seger, Hiroaki Yasui, Hilda van den Bos, Katarzyna Radke, Javanshir Esfandyari, Madhura Satish Bhave, Jenny Karlsson, Diana Carolina Johanna Spierings, Floris Foijer, David Gisselsson, Daniel Bexell
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance. Science advances 8 (43) (2022)
Karin Hansson, Katarzyna Radke, Kristina Aaltonen, Jani Saarela, Adriana Mañas, Jonas Sjölund, Emma M Smith, Kristian Pietras, Sven Påhlman, Krister Wennerberg, David Gisselsson, Daniel Bexell
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Science translational medicine 12 (562) (2021)